Cited by 22Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research AdvancesEar and Head Tumors

Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene

Open access
Griniatsos, John E, Dimitriou, Nikoletta, Zilos, Athanassios, Sakellariou, Stratigoula, Evangelou, Konstantinos, Kamakari, Smaragda, Korkolopoulou, Penelope, Kaltsas, Gregory·2011·World Journal of Surgical Oncology

Abstract

The incidence of adrenal involvement in MEN1 syndrome has been reported between 9 and 45%, while the incidence of adrenocortical carcinoma (ACC) in MEN1 patients has been reported between 2.6 and 6%. In the literature data only unilateral development of ACCs in MEN1 patients has been reported. We report a 31 years-old female MEN1-patient, in whom hyperplasia of the parathyroid glands, prolactinoma, non functioning pancreatic endocrine carcinoma and functioning bilateral adrenal carcinomas were diagnosed. Interestingly, a not previously described in the literature data, novel germline mutation (p.E45V) in exon 2 of MEN1 gene, was detected. The association of exon 2 mutation of the MEN1 gene with bilateral adrenal carcinomas in MEN1 syndrome, should be further investigated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-7819-9-6

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A small fraction of patients with MEN1 will develop ACC.

    “A small fraction of patients with MEN1 will develop ACC (46–51).”

    From Adrenocortical carcinoma (2014) · cites this paper as [49]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Griniatsos, J. E., Dimitriou, N., Zilos, A., Sakellariou, S., Evangelou, K., Kamakari, S., Korkolopoulou, P., & Kaltsas, G.
Affiliations
National and Kapodistrian University of Athens (GR)
Venue
World Journal of Surgical Oncology
Published
2011-01-25
Volume
9
Issue
1
Pages
6-6
ISSN
1477-7819 (ISSN-L)
OpenAlex
W2110454811
Cited by
22
References
39
Citations by year
2024: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
FWCI
2.62
Type
journal article
Language
en
Open access
Locations
  • World Journal of Surgical Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
Keywords
adrenocortical carcinoma, multiple endocrine neoplasia type 1, MEN1 gene, exon 2, parathyroid hyperplasia, prolactinoma, pancreatic neuroendocrine tumors
MeSH terms
Adrenal Cortex Neoplasms, Adult, Exons, Female, Humans, Prognosis, Proto-Oncogene Proteins, Germ-Line Mutation, Adrenocortical Carcinoma, Multiple Endocrine Neoplasia Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review